Aprea therapeutics, inc. APRE.US AI Analysis
BetaUS StockHealthcare
(No presentation for APRE)
APRE Dividend Score
3
24
15
No Dividend
Analysis Conclusion
The stock's dividend rating is at its lowest, making it unsuitable for a dividend-focused investment strategy.
APRE Dividend Reference Factor
Avg. Yield
0%
Avg. Volatility
79.24%
Avg. Filling Rate
-
Avg. Filling Days
-
Consequent Years
0
No related data records